Atossa Therapeutics (YAG.F) Q1 2026 Earnings

25MarConfirmed
Q4 2025
Q1 2026
-1.03
-0.97
-0.9
-0.84

Details

Expected EPS
-0.983948875
Actual EPS
-1.0293618999999998
Surprise EPS
-0.05
Surprise Percent
+4.62%

Description

Atossa Therapeutics (YAG.F) has reported earnings of -1.0293618999999998 per share for Q1 2026.

0 Comments

Share your thoughts